Accelerating Biotech Treatment Development with Amazon Omics
- Why AWS developed Amazon Omics – what are the challenges in the industry that led to this investment?
- What is Amazon Omics?
- How would a biotech firm who is currently leveraging AWS start to adopt the features of Amazon Omics?
- What benefits could biotech firms see from the adoption?
- How companies like PTP can assist in the adoption and ongoing management of AWS environments leveraging Amazon Omics to drive treatments and therapies.
Lee Pang, Principal Bioinformatics Architect, AWS
Lee is a Principal Bioinformatics Architect with the Health AI services team at AWS. He has a PhD in Bioengineering and over a decade of hands-on experience as a practicing research scientist and software engineer in bioinformatics, computational systems biology, and data science developing tools ranging from high throughput pipelines for *omics data processing to compliant software for clinical data capture and analysis.
Aaron Jeskey, Sr. Cloud Architect, PTP
What is PTP CloudOps? Learn More HERE
More about AWS’s Amazon Omics Launch? Learn more HERE